Xencor (XNCR) Net Equity Issued and Repurchased (2013 - 2018)

Xencor (XNCR) posted quarterly Net Equity Issued and Repurchased of $260.2 million for Q1 2018, up 111.74% quarter-over-quarter from $122.9 million in Q1 2015.

Xencor (XNCR) Net Equity Issued and Repurchased (2013 - 2018) Analysis & Trends

Xencor (XNCR) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $260.2 million the latest figure, recorded in Q1 2018.

  • In Q1 2018, Net Equity Issued and Repurchased changed N/A year-over-year to $260.2 million; the TTM figure through Dec 2018 stood at $260.2 million (changed N/A YoY), while the FY2024 annual figure was $201.3 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased advanced to $260.2 million in Q1 2018 per XNCR's latest filing, from $122.9 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $260.2 million in Q1 2018 and bottomed at $122.9 million in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Xencor 1.73 Bn 1.36 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2018 260.25 Mn
Mar 31, 2018 260.25 Mn
Mar 31, 2015 122.91 Mn
Mar 31, 2015 122.91 Mn
Dec 31, 2013 70.52 Mn
Dec 31, 2013 70.52 Mn
Sep 30, 2013 2.40 Mn
Sep 30, 2013 2.40 Mn
Jun 30, 2013 10.00 Mn
Jun 30, 2013 10.00 Mn